Forvis Mazars Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.42M | Sell |
|
|||||
|
2025
Q2 | $2.99M | Sell |
|
|||||
|
2025
Q1 | $3.79M | Buy |
|
|||||
|
2024
Q4 | $3.73M | Sell |
|
|||||
|
2024
Q3 | $4.58M | Buy |
|
|||||
|
2024
Q2 | $3.95M | Sell |
|
|||||
|
2024
Q1 | $4.23M | Buy |
|
|||||
|
2023
Q4 | $3.46M | Buy |
|
|||||
|
2023
Q3 | $3.27M | Sell |
|
|||||
|
2023
Q2 | $4.51M | Buy |
|
|||||
|
2023
Q1 | $3.84M | Buy |
|
|||||
|
2022
Q4 | $3.37M | Buy |
|
|||||
|
2022
Q3 | $3.04M | Buy |
|
|||||
|
2022
Q2 | $3.14M | Buy |
|
|||||
|
2022
Q1 | $3.26M | Buy |
|
|||||
|
2021
Q4 | $3.15M | Buy |
|
|||||
|
2021
Q3 | $2.61M | Buy |
|
|||||
|
2021
Q2 | $2.11M | Sell |
|
|||||
|
2021
Q1 | $1.97M | Sell |
|
|||||
|
2020
Q4 | $3.02M | Buy |
|
|||||
|
2020
Q3 | $2.4M | Buy |
|
|||||
|
2020
Q2 | $1.9M | Buy |
|
|||||
|
2020
Q1 | $1.3M | Buy |
|
|||||
|
2019
Q4 | $1.43M | Buy |
|
|||||
|
2019
Q3 | $1.25M | Buy |
|
|||||
|
2019
Q2 | $1.24M | Buy |
|
|||||
|
2019
Q1 | $696K | Buy |
|
|||||
|
2018
Q4 | $536K | Buy |
|
|||||
|
2018
Q3 | $572K | Buy |
|
|||||
|
2018
Q2 | $222K | Sell |
|
|||||
|
2018
Q1 | $341K | Buy |
|
|||||
|
2017
Q4 | $206K | Sell |
|
|||||
|
2017
Q3 | $222K | Sell |
|
|||||
|
2017
Q2 | $220K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $205K | Buy |
|